Key Peptides That Support Prolotherapy It is recommended to use a combination of injectable peptides to enhance the benefits of prolotherapy, including: GLOW (BPC-157 + TB-500 + GHK-Cu) GLOW is a proprietary blend of three synergistic peptides designed to promote comprehensive tissue regeneration: BPC-157 (5mg) : Enhances tendon and ligament healing, reduces inflammation, improves angiogenesis TB-500 (10mg) : Supports cell migration, modulates inflammation, prevents scar tissue GHK-Cu (27mg) : Stimulates collagen and elastin, improves skin and soft tissue repair GLOW is ideal in the early healing phase post-prolotherapy to amplify fibroblast activity and new capillary formation , both crucial for regenerative success
The classical metastatic cascade starts from a primary, epithelial, neoplastic lesion and includes: (1) epithelial mesenchymal transition (EMT) with a breach of the basement membrane barrier
A history of miscarriage (OR 1.3 [95% CI 1.0-1.8]), stillbirth (OR 4.8 [95% CI 1.6-17.8]), gestational diabetes (OR 2.6 [95% CI 1.3-5.3]), HDP (OR 2.0 [95% CI 1.4-2.7]), preterm birth (OR 2.7 [95% CI 1.9-4.0]), and SGA (OR 2.8 [95% CI 2.0-3.9]) were associated with an increased risk of ischemic stroke at young age
Our approach includes carefully selected lipotropic compounds paired with B12 to support metabolism, liver health, and energy
